TUNITAS THERAPEUTICS
Tunitas Therapeutics is a privately held biopharmaceutical company that is poised to develop unique and precisely targeted protein therapeutics that will dramatically change the lives of allergy sufferers. With Tunitas’ proteins, patients receive a treatment regimen in their allergist’s office that will alter the natural course of their disease, providing a therapeutic option with long-lasting benefit.
TUNITAS THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2008-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.tunitastherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(650)887-4747
Email Addresses:
[email protected]
Total Funding:
10 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Nginx DigiCert SSL CloudFront Google Adsense AdBlock Acceptable Ads Google Adsense For Domains Thawte SSL
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Investors List
RA Capital Advisors LLC
RA Capital Advisors LLC investment in Series A - Tunitas Therapeutics
WuXi Healthcare Ventures
WuXi Healthcare Ventures investment in Series A - Tunitas Therapeutics
Ally Bridge Group
Ally Bridge Group investment in Series A - Tunitas Therapeutics
Official Site Inspections
http://www.tunitastherapeutics.com
- Host name: 104.247.81.52
- IP address: 104.247.81.52
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
